These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2201546)

  • 1. A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells.
    Rénia L; Mattei D; Goma J; Pied S; Dubois P; Miltgen F; Nüssler A; Matile H; Menégaux F; Gentilini M
    Eur J Immunol; 1990 Jul; 20(7):1445-9. PubMed ID: 2201546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 induced by IL-1 inhibits malaria pre-erythrocytic stages but its secretion is down-regulated by the parasite.
    Pied S; Civas A; Berlot-Picard F; Renia L; Miltgen F; Gentilini M; Doly J; Mazier D
    J Immunol; 1992 Jan; 148(1):197-201. PubMed ID: 1727866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.
    Behr C; Sarthou JL; Rogier C; Trape JF; Dat MH; Michel JC; Aribot G; Dieye A; Claverie JM; Druihle P
    J Immunol; 1992 Nov; 149(10):3321-30. PubMed ID: 1431109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface expressed heat-shock proteins by stressed or human immunodeficiency virus (HIV)-infected lymphoid cells represent the target for antibody-dependent cellular cytotoxicity.
    Di Cesare S; Poccia F; Mastino A; Colizzi V
    Immunology; 1992 Jun; 76(2):341-3. PubMed ID: 1634255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
    Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
    Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific antibody-dependent cellular cytotoxicity in human malaria.
    Brown J; Smalley ME
    Clin Exp Immunol; 1980 Sep; 41(3):423-9. PubMed ID: 7002397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM; Majarian WR; Young JF; Daly TM; Long CA
    J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual action of anti-sporozoite antibodies in vitro.
    Nudelman S; Rénia L; Charoenvit Y; Yuan L; Miltgen F; Beaudoin RL; Mazier D
    J Immunol; 1989 Aug; 143(3):996-1000. PubMed ID: 2745980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected problems of malaria blood stage immunity.
    Perlmann P; Perlmann H; Berzins K; Troye-Blomberg M
    Tokai J Exp Clin Med; 1998 Apr; 23(2):55-62. PubMed ID: 10021776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells.
    Mazier D; Rénia L; Nussler A; Pied S; Marussig M; Goma J; Grillot D; Miltgen F; Drapier JC; Corradin G
    Immunol Lett; 1990 Aug; 25(1-3):65-70. PubMed ID: 1980910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of intermediate T cell receptor cells, mainly their NK1.1(-) subset, with protection from malaria.
    Weerasinghe A; Sekikawa H; Watanabe H; Mannoor K; Morshed SR; Halder RC; Kawamura T; Kosaka T; Miyaji C; Kawamura H; Seki S; Abo T
    Cell Immunol; 2001 Jan; 207(1):28-35. PubMed ID: 11161450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells.
    Soulard V; Roland J; Sellier C; Gruner AC; Leite-de-Moraes M; Franetich JF; Rénia L; Cazenave PA; Pied S
    Infect Immun; 2007 May; 75(5):2511-22. PubMed ID: 17307938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL; Daly TM; Clynes R; Long CA
    J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.